裴米索注射液３毫克/毫升
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Patient Information leaflet
(PIL)
14-06-2021
Public Assessment Report
(PAR)
10-04-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DISODIUM PAMIDRONATE
Available from:
輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708)
ATC code:
M05BA03
Pharmaceutical form:
注射劑
Composition:
DISODIUM PAMIDRONATE (9200050110) MG
Units in package:
小瓶;;盒裝
Class:
製 劑
Prescription type:
限由醫師使用
Manufactured by:
HOSPIRA AUSTRALIA PTY LTD 1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA AU
Therapeutic area:
pamidronic acid
Therapeutic indications:
惡性腫瘤之蝕骨性骨頭轉移、惡性高血鈣症。
Product summary:
有效日期: 2028/01/22; 英文品名: PAMISOL CONCENTRATED INJECTION 3MG/ML
Authorization date:
2003-01-22
Patient Information leaflet
HIP03-04
HIP03-04
Read the complete document
